Plain-English translation of NCT06098417 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are looking for new blood tests that can help detect fatty liver disease earlier and predict how serious it might become. Currently, the only way to know for sure if someone has fatty liver disease is through a liver biopsy—a procedure where doctors take a small piece of liver tissue. This study hopes to find simpler blood tests that could spot the disease without a biopsy.
Fatty liver disease is becoming increasingly common in people who are overweight or obese, but there's no good way to screen for it or catch it early. If doctors could identify the disease sooner with a simple blood test, patients might be more motivated to make healthy lifestyle changes before the disease causes serious damage.
You likely qualify if…
You likely don't qualify if…
As a participant, you would donate blood samples that researchers will analyze to find new markers of fatty liver disease. You would also have ultrasound imaging and elastography (a special ultrasound that measures liver stiffness) performed to see how your liver is doing. The study involves about 500 people total and is currently recruiting participants.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Italy
Enrollment target
~500 participants
Started
September 2015
Primary completion
September 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in October 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Silvia Palmisano, MD
University of Trieste
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.